[VRTX] YoY Quarter Result on 31-Dec-2019 [#Q4]

Stock
[VRTX] Vertex Pharmaceuticals Incorporated
Announcement Date
13-Feb-2020
Financial Year
2019
Quarter
31-Dec-2019 [#Q4]
Profit Trend
QoQ- 914.00%
YoY- -62.38%
Quarter Report
VRTX's Result
VRTX's Financial Summary
View:
Show?
Quarter Result
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
Revenue 2,302,700 2,072,600 1,627,820 1,413,265 870,106 651,634 458,706 30.83%
PBT 1,076,800 870,900 888,623 676,950 32,497 112,442 20,306 93.77%
Tax 257,900 100,800 284,433 93,716 -1,492,599 10,257 -7,453 -
NP 818,900 770,100 604,190 583,234 1,550,527 100,684 32,945 70.79%
Tax Rate -23.95% -11.57% -32.01% -13.84% 4,593.04% -9.12% 36.70% -
Total Cost 1,483,800 1,302,500 1,023,630 830,031 -680,421 550,950 425,761 23.11%
Ratio Analysis
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
NP Margin 35.56 37.16 37.12 41.27 178.20 15.45 7.18 30.54%
Per Share
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
EPS 3.19 3.02 2.32 2.26 6.08 0.40 0.13 70.42%
EPS Diluted 3.15 3.00 2.30 2.23 5.97 0.39 0.13 70.06%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.